Lakosamid
Klinički podaci
AHFS/Drugs.com
Monografija
Identifikatori
CAS broj
175481-36-4
ATC kod
N03 AX18
PubChem [ 1] [ 2]
219078
DrugBank
DB06218
ChemSpider [ 3]
189902
ChEMBL [ 4]
CHEMBL58323 Y
Hemijski podaci
Formula
C 13 H 18 N 2 O 3
Mol. masa
250,294
SMILES
eMolekuli & PubHem
InChI
InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1 Key: VPPJLAIAVCUEMN-GFCCVEGCSA-N Y
Fizički podaci
Tačka ključanja
536.4 °C (998 °F)
Farmakokinetički podaci
Poluvreme eliminacije
13 h
Izlučivanje
Renalno
Farmakoinformacioni podaci
Trudnoća
?
Pravni status
Način primene
Intravenozno, oralno
Lakosamid je organsko jedinjenje , koje sadrži 13 atoma ugljenika i ima molekulsku masu od 250,294 Da .[ 5] [ 6] [ 7] [ 8]
↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.” . Drug Discov Today 15 (23-24): 1052-7. DOI :10.1016/j.drudis.2010.10.003 . PMID 20970519 . edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4 : 217-241. DOI :10.1016/S1574-1400(08)00012-1 .
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining” . J Cheminform 2 (1): 3. DOI :10.1186/1758-2946-2-3 . PMID 20331846 . edit
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI :10.1093/nar/gkr777 . PMID 21948594 . edit
↑ Sheets PL, Heers C, Stoehr T, Cummins TR: Differential block of sensory neuronal voltage-gated sodium channels by lacosamide, lidocaine and carbamazepine. J Pharmacol Exp Ther. 2008 Mar 31;. PMID 18378801
↑ Jones GL, Popli GS, Silvia MT: Lacosamide-induced valproic Acid toxicity. Pediatr Neurol. 2013 Apr;48(4):308-10. doi: 10.1016/j.pediatrneurol.2012.12.039. PMID 23498565 23498565
↑ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs” . Nucleic Acids Res. 39 (Database issue): D1035-41. DOI :10.1093/nar/gkq1126 . PMC 3013709 . PMID 21059682 . edit
↑ David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets” . Nucleic Acids Res 36 (Database issue): D901-6. DOI :10.1093/nar/gkm958 . PMC 2238889 . PMID 18048412 . edit
↑ Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods” . J. Phys. Chem. A 102 : 3762-3772. DOI :10.1021/jp980230o .
↑ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices” . Chem Inf. Comput. Sci. 41 : 1488-1493. DOI :10.1021/ci000392t . PMID 11749573 . edit
↑ Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties” . J. Med. Chem. 43 : 3714-3717. DOI :10.1021/jm000942e . PMID 11020286 . edit
Jonotropni
Agonisti: Konkurentni agonisti :
Aspartat •
Glutamat •
Homokinolinska kiselina •
Ibotenska kiselina •
NMDA •
Kinolinska kiselina •
Tetrazolilglicin ;
Agonisti glicinskog mesta: ACBD •
ACPC •
ACPD •
Alanin •
CCG •
Cikloserin •
DHPG •
Fluoroalanin •
Glicin •
HA-966 •
L-687,414 •
Milacemid •
Sarkozin •
Serin •
Tetrazolilglicin ;
Agonisti poliaminskog mesta: Akamprosat •
Spermidin •
Spermin Antagonisti : Konkurentni antagonisti: AP5 (APV) •
AP7 •
CGP-37849 •
CGP-39551 •
CGP-39653 •
CGP-40116 •
CGS-19755 •
CPP •
LY-233,053 •
LY-235,959 •
LY-274,614 •
MDL-100,453 •
Midafotel (d-CPPen) •
NPC-12,626 •
NPC-17,742 •
PBPD •
PEAQX •
Perzinfotel •
PPDA •
SDZ-220581 •
Selfotel ;
Nekonkurentni antagonisti: ARR-15,896 •
Karoverin •
Deksanabinol •
FPL-12495 •
FR-115,427 •
Hodgkinsin •
Magnezijum •
MDL-27,266 •
NPS-1506 •
Psihotridin •
Cink ;
Nekonkurentni blokatori pora: 2-MDP •
3-MeO-PCP •
8A-PDHQ •
Amantadin •
Aptiganel •
ARL-12,495 •
ARL-15,896-AR •
ARL-16,247 •
Budipin •
Delucemin •
Deksoksadrol •
Dekstralorfan •
Dieticiklidin •
Dizocilpin •
Endopsihozin •
Esketamin •
Etoksadrol •
Eticiklidin •
Gaciklidin •
Ibogain •
Indantadol •
Ketamin •
Ketobemidon •
Loperamid •
Memantin •
Meperidin (Petidin) •
Metadon •
Metorfan (
Dekstrometorfan ,
Levometorfan ) •
Metoksetamin •
Milnacipran •
Morfanol (
Dekstrorfan ,
Levorfanol ) •
NEFA •
Nerameksan •
Azotsuboksid •
Noribogain •
Orfenadrin •
PCPr •
Fenciklamin •
Fenciklidin •
Propoksifen •
Remacemid •
Rinhofilin •
Riluzol •
Rimantadin •
Roliciklidin •
Sabeluzol •
Tenociklidin •
Tiletamin •
Tramadol •
Ksenon ;
Antagonisti glicinskog mesta: ACEA-1021 •
ACEA-1328 •
ACPC •
Karisoprodol •
CGP-39653 •
CKA •
DCKA •
Felbamat •
Gavestinel •
GV-196,771 •
Kinurenska kiselina •
L-689,560 •
L-701,324 •
Lakosamid •
Likostinel •
LU-73,068 •
MDL-105,519 •
Meprobamat •
MRZ 2/576 •
PNQX •
ZD-9379 ;
Antagonisti NR2B podjedinice: Bezonprodil •
CO-101,244 (PD-174,494) •
CP-101,606 •
Eliprodil •
Haloperidol •
Ifenprodil •
Izoksuprin •
Nilidrin •
Ro8-4304 •
Ro25-6981 •
Traksoprodil ;
Neklasifikovani/nesortirani antagonisti: Hloroform •
Dietil etar •
Enfluran •
Etanol (Alkohol) •
Halotan •
Izofluran •
Metoksifluran •
Toluen •
Trihloroetan •
Trihloroetanol •
Trihloroetilen •
Ksilen
Metabotropni
Inhibitori transporta